KETOPROFEN

KETOPROFEN was reported 13429 times

KETOPROFEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 30 0.4286
1 EPIDURAL ANALGESIA 10 0.3125
2 DEVICE WIRELESS COMMUNICATION ISSUE 69 0.2664
3 POLYNEUROPATHY IN MALIGNANT DISEASE 18 0.2195
4 TEMPERATURE REGULATION DISORDER 481 0.2157
5 SPINAL EPIDURAL HAEMORRHAGE 16 0.1975
6 ENCEPHALITIS BACTERIAL 10 0.1961
7 DEVICE MAINTENANCE ISSUE 101 0.1718
8 DIFFUSE AXONAL INJURY 13 0.1566
9 ALLERGY TEST NEGATIVE 23 0.1474
10 UNEVALUABLE DEVICE ISSUE 13 0.1461
11 INFUSION SITE INJURY 25 0.1420
12 EPIDURAL HAEMORRHAGE 14 0.1077
13 PRODUCT ADMINISTRATION ISSUE 20 0.0957
14 INFUSION SITE SCAB 11 0.0894
15 INFUSION SITE DISCHARGE 149 0.0849
16 INFUSION SITE IRRITATION 105 0.0817
17 INFUSION SITE INDURATION 118 0.0796
18 CONFUSION POSTOPERATIVE 10 0.0763
19 HETEROPHORIA 11 0.0759
20 FOOD ALLERGY 583 0.0755
21 INFUSION SITE HAEMORRHAGE 237 0.0720
22 INFUSION SITE WARMTH 87 0.0710
23 INFUSION SITE NODULE 67 0.0697
24 INFUSION SITE INFECTION 159 0.0684
25 INFUSION SITE INFLAMMATION 48 0.0680
26 INFUSION SITE DISCOLOURATION 59 0.0670
27 INFUSION SITE PAIN 828 0.0642
28 INFUSION SITE ERYTHEMA 516 0.0611
29 PATIENT DISSATISFACTION WITH DEVICE 15 0.0595
30 INFUSION SITE SWELLING 362 0.0575
31 FOETAL DEATH 293 0.0564
32 DEVICE INFUSION ISSUE 136 0.0548
33 INFUSION SITE CELLULITIS 26 0.0492
34 CENTRAL PAIN SYNDROME 12 0.0453
35 NSAID EXACERBATED RESPIRATORY DISEASE 17 0.0450
36 COELIAC DISEASE 432 0.0440
37 MIGRAINE WITHOUT AURA 13 0.0433
38 INFUSION SITE DISCOMFORT 44 0.0424
39 INFUSION SITE REACTION 126 0.0421
40 IMMUNODEFICIENCY 602 0.0403
41 INFUSION SITE PRURITUS 116 0.0367
42 BURSITIS 445 0.0366
43 INFUSION SITE MASS 37 0.0340
44 PHONOPHOBIA 15 0.0326
45 DISABILITY ASSESSMENT SCALE SCORE INCREASED 10 0.0326
46 INFUSION SITE VESICLES 17 0.0323
47 DERMO-HYPODERMITIS 19 0.0319
48 SACRAL PAIN 19 0.0312
49 INFUSION SITE RASH 40 0.0291
50 ANISOCORIA 11 0.0291
51 INFUSION SITE ABSCESS 14 0.0278
52 NEPHRITIS ALLERGIC 11 0.0277
53 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 17 0.0276
54 ELECTROCARDIOGRAM T WAVE PEAKED 11 0.0274
55 INFUSION SITE SCAR 12 0.0271
56 ENDOCARDITIS STAPHYLOCOCCAL 13 0.0264
57 LIMB REDUCTION DEFECT 15 0.0257
58 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 14 0.0250
59 DEVICE POWER SOURCE ISSUE 72 0.0246
60 GASTRODUODENAL ULCER 10 0.0238
61 HYPERLEUKOCYTOSIS 21 0.0237
62 FRACTURE DISPLACEMENT 10 0.0233
63 INFUSION SITE BRUISING 50 0.0231
64 DEVICE ALARM ISSUE 42 0.0231
65 OCCIPITAL NEURALGIA 13 0.0230
66 RETROGRADE AMNESIA 11 0.0217
67 PRESCRIBED OVERDOSE 409 0.0211
68 PERIPHERAL NERVE INJURY 18 0.0205
69 BURNING MOUTH SYNDROME 11 0.0194
70 VASCULAR PURPURA 27 0.0193
71 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 19 0.0189
72 HYPOAESTHESIA EYE 11 0.0186
73 CROSS SENSITIVITY REACTION 18 0.0185
74 FOETAL HEART RATE ABNORMAL 17 0.0184
75 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 140 0.0180
76 MYOCLONIC EPILEPSY 26 0.0171
77 DEVICE CONNECTION ISSUE 35 0.0166
78 POISONING DELIBERATE 157 0.0165
79 PURULENT DISCHARGE 69 0.0161
80 PROTHROMBIN TIME ABNORMAL 11 0.0159
81 PULMONARY PAIN 46 0.0157
82 ALLODYNIA 17 0.0145
83 CYTOLYTIC HEPATITIS 47 0.0141
84 DEVICE ELECTRICAL FINDING 10 0.0141
85 CONTRAINDICATED PRODUCT ADMINISTERED 421 0.0139
86 PALATAL OEDEMA 17 0.0137
87 INFUSION SITE OEDEMA 11 0.0132
88 DIARRHOEA INFECTIOUS 10 0.0127
89 MIXED LIVER INJURY 38 0.0126
90 UPPER RESPIRATORY TRACT INFECTION 575 0.0124
91 PO2 DECREASED 14 0.0122
92 FINE MOTOR SKILL DYSFUNCTION 35 0.0121
93 RASH ERYTHEMATOUS 567 0.0118
94 GOITRE 48 0.0117
95 UPPER RESPIRATORY TRACT INFLAMMATION 14 0.0117
96 FIXED ERUPTION 20 0.0116
97 PROTHROMBIN TIME SHORTENED 16 0.0114
98 INTERVERTEBRAL DISCITIS 21 0.0111
99 FLUID RETENTION 561 0.0110
100 DISCHARGE 15 0.0108
101 CATHETER SITE SWELLING 10 0.0107
102 HEPATIC CYTOLYSIS 133 0.0104
103 TYPE I HYPERSENSITIVITY 35 0.0099
104 DERMATITIS CONTACT 110 0.0096
105 HEPATIC ENZYME INCREASED 634 0.0093
106 EXOPHTHALMOS 20 0.0093
107 HYPERAESTHESIA 76 0.0092
108 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 18 0.0091
109 CATHETER SITE DISCHARGE 10 0.0089
110 WHITE MATTER LESION 11 0.0087
111 CATHETER SITE ERYTHEMA 18 0.0084
112 DEVICE OCCLUSION 115 0.0082
113 PYELONEPHRITIS ACUTE 16 0.0082
114 GASTRITIS EROSIVE 38 0.0081
115 HYPERVOLAEMIA 40 0.0081
116 CLUSTER HEADACHE 11 0.0080
117 FOOD INTERACTION 14 0.0079
118 HAEMOGLOBIN INCREASED 36 0.0079
119 MENOMETRORRHAGIA 15 0.0079
120 LIP OEDEMA 33 0.0078
121 EXPOSURE DURING PREGNANCY 483 0.0078
122 GASTRIC ULCER HAEMORRHAGE 43 0.0078
123 DEVICE FAILURE 118 0.0077
124 RENAL INFARCT 11 0.0076
125 MUTISM 11 0.0076
126 DECREASED IMMUNE RESPONSIVENESS 74 0.0075
127 OXYGEN CONSUMPTION INCREASED 18 0.0075
128 ANORGASMIA 20 0.0074
129 QUADRIPLEGIA 15 0.0073
130 LINEAR IGA DISEASE 12 0.0072
131 DEVICE PLACEMENT ISSUE 25 0.0070
132 LIVEDO RETICULARIS 14 0.0067
133 INFUSION RELATED REACTION 441 0.0066
134 BLOOD LOSS ANAEMIA 15 0.0066
135 CUTANEOUS VASCULITIS 24 0.0066
136 CATHETER SITE PAIN 17 0.0065
137 RHEUMATOID ARTHRITIS 712 0.0063
138 CHOLESTASIS 119 0.0062
139 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0062
140 ANAPHYLACTIC SHOCK 158 0.0061
141 ENTEROCOLITIS 35 0.0061
142 PRODUCT LEAKAGE 34 0.0061
143 NASAL DISORDER 16 0.0060
144 PNEUMOPERITONEUM 11 0.0059
145 ARTHRITIS BACTERIAL 24 0.0058
146 HEPATITIS ACUTE 38 0.0058
147 DEVICE PHYSICAL PROPERTY ISSUE 44 0.0057
148 HEPATITIS CHOLESTATIC 34 0.0056
149 ANGIOEDEMA 247 0.0056
150 DERMATITIS BULLOUS 40 0.0055
151 ASTHMA 623 0.0055
152 HYPERHIDROSIS 709 0.0055
153 HEPATOCELLULAR INJURY 78 0.0055
154 DIVERTICULAR PERFORATION 11 0.0053
155 INTENTIONAL PRODUCT MISUSE 464 0.0053
156 TOXIC SKIN ERUPTION 53 0.0053
157 DEVICE KINK 19 0.0052
158 CATHETER SITE HAEMORRHAGE 13 0.0052
159 MELAENA 114 0.0052
160 DEREALISATION 11 0.0051
161 HYPERAEMIA 10 0.0051
162 LEFT VENTRICULAR DYSFUNCTION 34 0.0051
163 HEPATITIS FULMINANT 15 0.0051
164 FACE OEDEMA 85 0.0050
165 ANURIA 43 0.0050
166 CHOLESTATIC LIVER INJURY 11 0.0049
167 BRONCHITIS CHRONIC 12 0.0049
168 DYSCHEZIA 15 0.0049
169 GASTRIC ULCER 92 0.0048
170 BRADYPNOEA 13 0.0048
171 PERSECUTORY DELUSION 12 0.0048
172 MIGRAINE WITH AURA 13 0.0048
173 CLUMSINESS 13 0.0048
174 AZOTAEMIA 19 0.0048
175 PANCREATITIS ACUTE 106 0.0047
176 FEMORAL NECK FRACTURE 24 0.0047
177 VENTRICULAR HYPOKINESIA 15 0.0047
178 DRUG TITRATION ERROR 12 0.0046
179 MYOPIA 11 0.0046
180 RADIUS FRACTURE 11 0.0046
181 DUODENAL ULCER HAEMORRHAGE 13 0.0045
182 JOINT SWELLING 545 0.0045
183 HAEMORRHAGIC DIATHESIS 16 0.0045
184 TONGUE OEDEMA 17 0.0045
185 STAPHYLOCOCCAL SEPSIS 22 0.0045
186 EOSINOPHILIA 78 0.0044
187 EYE INJURY 13 0.0043
188 DRUG TOLERANCE DECREASED 12 0.0043
189 RHINITIS ALLERGIC 19 0.0043
190 SELF INJURIOUS BEHAVIOUR 13 0.0043
191 DUODENAL ULCER 30 0.0042
192 ABDOMINAL TENDERNESS 21 0.0042
193 TOXIC EPIDERMAL NECROLYSIS 64 0.0042
194 VASCULAR DEVICE INFECTION 19 0.0042
195 THROMBOCYTOPENIA 465 0.0042
196 GINGIVAL PAIN 33 0.0041
197 DRUG INTOLERANCE 398 0.0041
198 MIOSIS 33 0.0041
199 FAECAL CALPROTECTIN INCREASED 13 0.0041
200 RASH MACULO-PAPULAR 91 0.0041
201 BRONCHOPNEUMONIA 14 0.0041
202 PRODUCT ADMINISTRATION INTERRUPTED 32 0.0041
203 AMYLASE INCREASED 15 0.0041
204 THERAPY NON-RESPONDER 182 0.0040
205 PAIN IN JAW 114 0.0040
206 UNINTENTIONAL MEDICAL DEVICE REMOVAL 46 0.0040
207 DEPRESSIVE SYMPTOM 14 0.0040
208 PULMONARY ARTERIAL HYPERTENSION 57 0.0039
209 BLOOD PRESSURE DIASTOLIC ABNORMAL 10 0.0039
210 COMMUNICATION DISORDER 15 0.0039
211 LACTIC ACIDOSIS 127 0.0039
212 HYPERSENSITIVITY 722 0.0039
213 EYELID OEDEMA 45 0.0039
214 DEVICE INFORMATION OUTPUT ISSUE 30 0.0038
215 TUBULOINTERSTITIAL NEPHRITIS 72 0.0038
216 MENINGITIS ASEPTIC 17 0.0038
217 LUMBAR SPINAL STENOSIS 11 0.0038
218 NECROTISING FASCIITIS 13 0.0037
219 TREATMENT FAILURE 303 0.0037
220 HYPERCAPNIA 11 0.0036
221 HYPERURICAEMIA 15 0.0036
222 OLIGURIA 22 0.0035
223 ACUTE KIDNEY INJURY 542 0.0035
224 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 31 0.0035
225 DEVICE DISLOCATION 151 0.0035
226 DIZZINESS POSTURAL 33 0.0034
227 PHOTOSENSITIVITY REACTION 56 0.0034
228 ANKYLOSING SPONDYLITIS 44 0.0033
229 IRON DEFICIENCY 15 0.0033
230 RETCHING 71 0.0033
231 SHOCK HAEMORRHAGIC 27 0.0033
232 PEPTIC ULCER 11 0.0033
233 RENAL FAILURE ACUTE 140 0.0033
234 BLOOD PRESSURE SYSTOLIC DECREASED 15 0.0033
235 INCORRECT DRUG ADMINISTRATION RATE 14 0.0033
236 METASTASES TO LUNG 38 0.0033
237 INFLAMMATORY BOWEL DISEASE 32 0.0033
238 COMA 154 0.0032
239 ALTERED STATE OF CONSCIOUSNESS 70 0.0032
240 ERYTHEMA 662 0.0032
241 SUICIDE ATTEMPT 195 0.0032
242 CARDIOGENIC SHOCK 46 0.0032
243 PLEURISY 19 0.0032
244 AFFECTIVE DISORDER 25 0.0032
245 RENAL TUBULAR NECROSIS 31 0.0032
246 PATHOLOGICAL FRACTURE 16 0.0031
247 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 81 0.0031
248 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 12 0.0031
249 THERAPY PARTIAL RESPONDER 49 0.0031
250 PYELONEPHRITIS 27 0.0031
251 COLITIS ISCHAEMIC 21 0.0031
252 FIBRIN D DIMER INCREASED 11 0.0031
253 DRUG LEVEL INCREASED 51 0.0031
254 CARDIOPULMONARY FAILURE 12 0.0031
255 VENOUS THROMBOSIS 12 0.0031
256 PULMONARY HYPERTENSION 63 0.0030
257 SPINAL COMPRESSION FRACTURE 25 0.0030
258 AUTOIMMUNE HEPATITIS 21 0.0030
259 ARTHRITIS INFECTIVE 14 0.0030
260 BACK PAIN 700 0.0030
261 ATRIOVENTRICULAR BLOCK COMPLETE 20 0.0030
262 CONSTIPATION 649 0.0030
263 PHLEBITIS 15 0.0029
264 HEPATIC NECROSIS 11 0.0029
265 OVERDOSE 629 0.0029
266 LEFT VENTRICULAR FAILURE 10 0.0029
267 OBESITY 46 0.0029
268 RASH PUSTULAR 21 0.0029
269 HYPERTRANSAMINASAEMIA 20 0.0029
270 PRODUCT USE ISSUE 540 0.0029
271 KNEE ARTHROPLASTY 60 0.0028
272 BONE EROSION 10 0.0028
273 IRON DEFICIENCY ANAEMIA 26 0.0028
274 METASTASES TO LYMPH NODES 19 0.0028
275 PALLOR 76 0.0028
276 DRUG INTERACTION 441 0.0028
277 OCULAR ICTERUS 12 0.0028
278 SEASONAL ALLERGY 39 0.0028
279 HYPERKALAEMIA 96 0.0027
280 LARGE INTESTINE PERFORATION 19 0.0027
281 SEPTIC SHOCK 119 0.0027
282 HYPERTENSION 575 0.0027
283 HYPOVOLAEMIC SHOCK 13 0.0027
284 INTENTIONAL OVERDOSE 174 0.0027
285 GAMMA-GLUTAMYLTRANSFERASE INCREASED 60 0.0027
286 POISONING 34 0.0027
287 DISSEMINATED INTRAVASCULAR COAGULATION 38 0.0027
288 DEVICE USE ERROR 93 0.0027
289 HYPOTHERMIA 27 0.0027
290 LEUKOCYTOSIS 48 0.0026
291 PSORIASIS 345 0.0026
292 HYPERTHERMIA 20 0.0026
293 BRAIN INJURY 26 0.0026
294 DECUBITUS ULCER 21 0.0026
295 INFLAMMATION 133 0.0026
296 LUNG NEOPLASM 11 0.0026
297 TACHYPNOEA 35 0.0026
298 DYSLIPIDAEMIA 13 0.0026
299 ASTHENOPIA 14 0.0025
300 INTESTINAL ISCHAEMIA 14 0.0025
301 LIGAMENT SPRAIN 25 0.0025
302 POLYNEUROPATHY 30 0.0025
303 HAEMORRHAGIC ANAEMIA 11 0.0025
304 RHINITIS 20 0.0025
305 GASTRITIS 65 0.0025
306 DYSPNOEA EXERTIONAL 93 0.0025
307 BLOOD LACTATE DEHYDROGENASE INCREASED 39 0.0025
308 LEUKOPENIA 123 0.0025
309 INFECTION 352 0.0024
310 ACUTE RESPIRATORY DISTRESS SYNDROME 43 0.0024
311 LOWER RESPIRATORY TRACT INFECTION 110 0.0024
312 HYPONATRAEMIA 136 0.0024
313 GASTROINTESTINAL PERFORATION 10 0.0024
314 SUPRAVENTRICULAR TACHYCARDIA 23 0.0024
315 DRUG LEVEL ABOVE THERAPEUTIC 11 0.0024
316 MENINGITIS 16 0.0024
317 NEURALGIA 58 0.0024
318 GENERAL PHYSICAL CONDITION ABNORMAL 16 0.0024
319 SUBARACHNOID HAEMORRHAGE 24 0.0024
320 ODYNOPHAGIA 14 0.0023
321 METABOLIC ACIDOSIS 75 0.0023
322 ENDOCARDITIS 12 0.0023
323 OXYGEN SATURATION DECREASED 131 0.0023
324 DRUG ABUSE 194 0.0023
325 ANOREXIA 30 0.0023
326 SKIN ABRASION 11 0.0023
327 INTERMENSTRUAL BLEEDING 13 0.0023
328 APHTHOUS ULCER 18 0.0023
329 PULSE ABSENT 11 0.0023
330 ATRIOVENTRICULAR BLOCK FIRST DEGREE 10 0.0023
331 BLOOD PRESSURE DIASTOLIC DECREASED 17 0.0023
332 TENDON DISORDER 15 0.0023
333 SUBCUTANEOUS ABSCESS 11 0.0023
334 EXERCISE TOLERANCE DECREASED 13 0.0023
335 CARDIAC FAILURE ACUTE 15 0.0022
336 INFUSION SITE EXTRAVASATION 14 0.0022
337 PYREXIA 776 0.0022
338 HEAVY MENSTRUAL BLEEDING 20 0.0022
339 MULTI-ORGAN FAILURE 38 0.0022
340 ACUTE HEPATIC FAILURE 30 0.0022
341 ERYSIPELAS 11 0.0022
342 JOINT EFFUSION 15 0.0022
343 HEPATIC FUNCTION ABNORMAL 81 0.0022
344 TYPE 1 DIABETES MELLITUS 13 0.0022
345 STREPTOCOCCAL INFECTION 12 0.0022
346 ANAPHYLACTIC REACTION 119 0.0022
347 PURPURA 19 0.0021
348 DERMATITIS ALLERGIC 27 0.0021
349 HEPATIC ENCEPHALOPATHY 20 0.0021
350 UPPER GASTROINTESTINAL HAEMORRHAGE 36 0.0021
351 HEPATOMEGALY 21 0.0021
352 METASTASES TO BONE 35 0.0021
353 DEVICE LEAKAGE 92 0.0021
354 TROPONIN INCREASED 16 0.0021
355 OSTEOMYELITIS 38 0.0021
356 AGRANULOCYTOSIS 39 0.0021
357 CHOLECYSTITIS CHRONIC 14 0.0021
358 BLOOD LACTIC ACID INCREASED 11 0.0021
359 ATELECTASIS 20 0.0021
360 URINARY RETENTION 69 0.0021
361 STRESS CARDIOMYOPATHY 12 0.0021
362 HYPOVOLAEMIA 12 0.0020
363 HAEMORRHAGIC STROKE 16 0.0020
364 BEHAVIOUR DISORDER 11 0.0020
365 HEADACHE 1272 0.0020
366 INTERSTITIAL LUNG DISEASE 98 0.0020
367 ENCEPHALITIS 14 0.0020
368 HAEMOGLOBIN ABNORMAL 13 0.0020
369 TENDERNESS 21 0.0020
370 BLOOD ALKALINE PHOSPHATASE INCREASED 50 0.0020
371 SUDDEN DEATH 21 0.0020
372 ARTHROPATHY 110 0.0020
373 SEROTONIN SYNDROME 38 0.0020
374 BRONCHOSPASM 28 0.0020
375 ACUTE PULMONARY OEDEMA 11 0.0020
376 DRUG ABUSER 12 0.0020
377 SLEEP APNOEA SYNDROME 37 0.0019
378 VISUAL FIELD DEFECT 14 0.0019
379 CHOLANGITIS 12 0.0019
380 GENERALISED ERYTHEMA 11 0.0019
381 DIARRHOEA HAEMORRHAGIC 18 0.0019
382 RESPIRATORY RATE INCREASED 17 0.0019
383 BLEPHAROSPASM 12 0.0019
384 BLOOD URIC ACID INCREASED 11 0.0019
385 HYPOXIA 67 0.0019
386 RALES 11 0.0019
387 PAIN 1163 0.0019
388 DEVICE ADHESION ISSUE 29 0.0019
389 THYROID DISORDER 29 0.0019
390 TACHYCARDIA 167 0.0019
391 HEPATITIS 48 0.0019
392 ALANINE AMINOTRANSFERASE INCREASED 115 0.0019
393 EYELID PTOSIS 19 0.0019
394 SHOCK 43 0.0019
395 COMPRESSION FRACTURE 10 0.0019
396 RIGHT VENTRICULAR FAILURE 13 0.0019
397 ANGINA UNSTABLE 12 0.0018
398 OEDEMA 100 0.0018
399 NERVE COMPRESSION 17 0.0018
400 ASPHYXIA 15 0.0018
401 HYDROCEPHALUS 10 0.0018
402 MUSCULOSKELETAL PAIN 96 0.0018
403 OESOPHAGITIS 20 0.0018
404 LIPASE INCREASED 14 0.0018
405 ASPARTATE AMINOTRANSFERASE INCREASED 97 0.0018
406 C-REACTIVE PROTEIN INCREASED 66 0.0018
407 PHOTOPHOBIA 34 0.0018
408 TENSION 11 0.0018
409 APNOEA 14 0.0018
410 LIVE BIRTH 15 0.0018
411 LARYNGEAL OEDEMA 11 0.0018
412 GASTROENTERITIS 26 0.0018
413 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17 0.0018
414 GENERALISED OEDEMA 22 0.0018
415 HAEMATEMESIS 45 0.0018
416 PRESYNCOPE 43 0.0018
417 CHOLECYSTITIS ACUTE 10 0.0018
418 SENSITIVE SKIN 13 0.0018
419 HYPERCHOLESTEROLAEMIA 17 0.0018
420 HEPATIC FAILURE 53 0.0018
421 MYOCARDIAL ISCHAEMIA 20 0.0018
422 TRANSAMINASES INCREASED 39 0.0018
423 EYE MOVEMENT DISORDER 12 0.0018
424 NEPHROTIC SYNDROME 12 0.0017
425 MULTIPLE INJURIES 11 0.0017
426 PNEUMONIA BACTERIAL 16 0.0017
427 BLOOD UREA INCREASED 29 0.0017
428 COORDINATION ABNORMAL 24 0.0017
429 ACUTE RESPIRATORY FAILURE 33 0.0017
430 MYDRIASIS 22 0.0017
431 C-REACTIVE PROTEIN ABNORMAL 11 0.0017
432 QUALITY OF LIFE DECREASED 23 0.0017
433 FOOT DEFORMITY 19 0.0017
434 HYPOTONIA 17 0.0017
435 ILEUS 21 0.0017
436 EMPHYSEMA 17 0.0017
437 FEMUR FRACTURE 52 0.0017
438 OSTEONECROSIS OF JAW 41 0.0017
439 PERICARDIAL EFFUSION 38 0.0016
440 DEVICE ISSUE 147 0.0016
441 VITAMIN D DECREASED 14 0.0016
442 SKIN REACTION 23 0.0016
443 OEDEMA PERIPHERAL 198 0.0016
444 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
445 TOXICITY TO VARIOUS AGENTS 273 0.0016
446 ERYTHEMA MULTIFORME 15 0.0016
447 PULMONARY OEDEMA 72 0.0016
448 HYPOTENSION 322 0.0016
449 TOOTHACHE 29 0.0016
450 MENINGIOMA 25 0.0016
451 ASCITES 47 0.0016
452 CHOLECYSTITIS 19 0.0016
453 GROIN PAIN 14 0.0016
454 SPINAL OSTEOARTHRITIS 14 0.0016
455 NECK PAIN 89 0.0016
456 BLOOD BILIRUBIN INCREASED 43 0.0016
457 LIVER INJURY 39 0.0016
458 ANAEMIA 303 0.0016
459 RASH 689 0.0016
460 HAEMODYNAMIC INSTABILITY 12 0.0016
461 TOOTH ABSCESS 16 0.0016
462 NERVOUS SYSTEM DISORDER 49 0.0016
463 CARDIAC FAILURE 125 0.0016
464 HAEMOLYSIS 12 0.0016
465 ATRIOVENTRICULAR BLOCK 12 0.0016
466 BRADYCARDIA 82 0.0015
467 VASCULITIS 18 0.0015
468 HYPOALBUMINAEMIA 12 0.0015
469 TORSADE DE POINTES 12 0.0015
470 PLEURAL EFFUSION 93 0.0015
471 NEPHROLITHIASIS 70 0.0015
472 INCREASED TENDENCY TO BRUISE 14 0.0015
473 PNEUMONIA ASPIRATION 38 0.0015
474 RENAL CYST 12 0.0015
475 TRICUSPID VALVE INCOMPETENCE 12 0.0015
476 STATUS EPILEPTICUS 17 0.0015
477 EPISTAXIS 112 0.0015
478 THYROID CANCER 18 0.0015
479 GASTROINTESTINAL HAEMORRHAGE 125 0.0015
480 HYPOPHOSPHATAEMIA 11 0.0015
481 JAUNDICE 40 0.0015
482 LYMPHOPENIA 21 0.0015
483 STEVENS-JOHNSON SYNDROME 33 0.0015
484 DECREASED ACTIVITY 16 0.0015
485 SINUS TACHYCARDIA 21 0.0015
486 HYPOKALAEMIA 68 0.0015
487 HAEMATOMA 38 0.0015
488 ABNORMAL FAECES 12 0.0015
489 INTERVERTEBRAL DISC PROTRUSION 32 0.0015
490 FACIAL PAIN 13 0.0015
491 TENDON PAIN 11 0.0015
492 PHARYNGITIS 18 0.0014
493 HAEMOLYTIC ANAEMIA 13 0.0014
494 COLITIS 55 0.0014
495 PNEUMOTHORAX 23 0.0014
496 EPILEPSY 44 0.0014
497 HAEMODIALYSIS 12 0.0014
498 STAPHYLOCOCCAL INFECTION 47 0.0014
499 MUSCULOSKELETAL STIFFNESS 124 0.0014
500 OVARIAN CYST 14 0.0014
501 VOMITING 657 0.0014
502 HEPATIC STEATOSIS 26 0.0014
503 BLOOD ALBUMIN DECREASED 11 0.0014
504 RESPIRATORY DISTRESS 38 0.0014
505 DRUG-INDUCED LIVER INJURY 43 0.0014
506 SPINAL PAIN 16 0.0014
507 INCREASED APPETITE 26 0.0014
508 URTICARIA 227 0.0014
509 DELIRIUM 47 0.0014
510 VENTRICULAR FIBRILLATION 15 0.0013
511 CIRCULATORY COLLAPSE 23 0.0013
512 HAEMATURIA 46 0.0013
513 LIVER DISORDER 59 0.0013
514 OROPHARYNGEAL DISCOMFORT 12 0.0013
515 EYE INFECTION 15 0.0013
516 BLOOD CREATINE PHOSPHOKINASE INCREASED 38 0.0013
517 RESPIRATORY FAILURE 96 0.0013
518 DYSPHAGIA 124 0.0013
519 GASTRIC HAEMORRHAGE 15 0.0013
520 DEVICE RELATED INFECTION 20 0.0013
521 INTERNATIONAL NORMALISED RATIO INCREASED 37 0.0013
522 INADEQUATE ANALGESIA 11 0.0013
523 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
524 TENDONITIS 20 0.0013
525 FAECES DISCOLOURED 28 0.0013
526 INTENTIONAL SELF-INJURY 26 0.0013
527 LUNG DISORDER 63 0.0013
528 URINARY INCONTINENCE 38 0.0013
529 HAEMORRHOIDS 25 0.0013
530 HYPOCALCAEMIA 24 0.0013
531 DEVICE MALFUNCTION 89 0.0013
532 SOMNOLENCE 255 0.0013
533 HELICOBACTER INFECTION 13 0.0013
534 PROTEINURIA 24 0.0013
535 HYPOAESTHESIA ORAL 19 0.0013
536 MYOCLONUS 15 0.0013
537 BLOOD CREATININE INCREASED 82 0.0013
538 MUSCLE RIGIDITY 15 0.0013
539 UVEITIS 17 0.0013
540 ERECTILE DYSFUNCTION 32 0.0012
541 CARDIO-RESPIRATORY ARREST 52 0.0012
542 WEIGHT FLUCTUATION 13 0.0012
543 ABDOMINAL PAIN 289 0.0012
544 DRUG ERUPTION 22 0.0012
545 MEDICATION ERROR 69 0.0012
546 ADRENAL INSUFFICIENCY 15 0.0012
547 SCHIZOPHRENIA 15 0.0012
548 LOSS OF CONSCIOUSNESS 158 0.0012
549 CEREBRAL INFARCTION 30 0.0012
550 FATIGUE 954 0.0012
551 SYNOVITIS 22 0.0012
552 RENAL FAILURE 162 0.0012
553 HAND DEFORMITY 16 0.0012
554 BREAST PAIN 13 0.0012
555 BODY TEMPERATURE DECREASED 12 0.0012
556 SWELLING 114 0.0012
557 DISABILITY 24 0.0012
558 DISORIENTATION 48 0.0012
559 GENERAL PHYSICAL HEALTH DETERIORATION 138 0.0012
560 CHOLELITHIASIS 39 0.0012
561 PERIPHERAL SWELLING 183 0.0012
562 WOUND INFECTION 13 0.0012
563 MIGRAINE 113 0.0012
564 BACTERAEMIA 14 0.0012
565 HYPERTHYROIDISM 17 0.0012
566 BLOOD PRESSURE DECREASED 78 0.0012
567 PANCREATITIS 62 0.0012
568 NEUTROPHIL COUNT INCREASED 12 0.0012
569 HYPERLIPIDAEMIA 14 0.0012
570 PAIN IN EXTREMITY 345 0.0012
571 CELLULITIS 59 0.0012
572 CONFUSIONAL STATE 189 0.0012
573 RECTAL HAEMORRHAGE 50 0.0012
574 ORAL DISCOMFORT 16 0.0012
575 CARDIOMYOPATHY 17 0.0011
576 HAEMOPTYSIS 32 0.0011
577 SINUS BRADYCARDIA 11 0.0011
578 PULMONARY EMBOLISM 108 0.0011
579 JOINT DISLOCATION 12 0.0011
580 TENDON RUPTURE 14 0.0011
581 DECREASED APPETITE 263 0.0011
582 LYMPHOCYTE COUNT DECREASED 20 0.0011
583 VITAMIN D DEFICIENCY 11 0.0011
584 ABDOMINAL PAIN UPPER 232 0.0011
585 DIARRHOEA 721 0.0011
586 IMPAIRED QUALITY OF LIFE 16 0.0011
587 PERITONITIS 23 0.0011
588 CHROMATURIA 25 0.0011
589 RESTLESS LEGS SYNDROME 20 0.0011
590 MUSCULOSKELETAL CHEST PAIN 17 0.0011
591 BLOOD POTASSIUM DECREASED 33 0.0011
592 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
593 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
594 SKIN ULCER 28 0.0011
595 EAR PAIN 21 0.0011
596 ASTHENIA 406 0.0011
597 NERVE INJURY 12 0.0011
598 RHABDOMYOLYSIS 45 0.0011
599 IMPAIRED WORK ABILITY 23 0.0011
600 DYSPNOEA 609 0.0011
601 PULMONARY MASS 16 0.0011
602 WOUND 30 0.0011
603 THROAT TIGHTNESS 29 0.0011
604 BACTERIAL INFECTION 20 0.0011
605 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 76 0.0011
606 CYSTITIS 34 0.0011
607 TOOTH INFECTION 14 0.0011
608 DEPRESSED LEVEL OF CONSCIOUSNESS 42 0.0011
609 FRACTURE 20 0.0011
610 NAUSEA 836 0.0011
611 OSTEOPENIA 16 0.0011
612 PETECHIAE 11 0.0011
613 UPPER LIMB FRACTURE 21 0.0011
614 VERTIGO 64 0.0010
615 SEPSIS 117 0.0010
616 BLOOD POTASSIUM INCREASED 17 0.0010
617 CONDITION AGGRAVATED 318 0.0010
618 POST PROCEDURAL COMPLICATION 20 0.0010
619 PHARYNGEAL OEDEMA 16 0.0010
620 ORTHOSTATIC HYPOTENSION 18 0.0010
621 DELUSION 16 0.0010
622 APATHY 15 0.0010
623 RASH PAPULAR 23 0.0010
624 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29 0.0010
625 CYANOSIS 16 0.0010
626 ARTHRITIS 80 0.0010
627 ARRHYTHMIA 48 0.0010
628 RESPIRATORY TRACT CONGESTION 16 0.0010
629 MYALGIA 171 0.0010
630 CHEST PAIN 186 0.0010
631 EYE DISORDER 33 0.0010
632 SCIATICA 16 0.0010
633 RESPIRATORY DISORDER 30 0.0010
634 BLOOD PRESSURE FLUCTUATION 24 0.0010
635 DIABETES MELLITUS 76 0.0010
636 INFLUENZA 111 0.0010
637 SCAR 17 0.0010
638 WEIGHT DECREASED 277 0.0010
639 VIRAL INFECTION 33 0.0010
640 OSTEOARTHRITIS 42 0.0010
641 WHITE BLOOD CELL COUNT INCREASED 38 0.0010
642 HEART RATE INCREASED 98 0.0010
643 NOCTURIA 12 0.0010
644 ORAL CANDIDIASIS 13 0.0010
645 FIBROMYALGIA 24 0.0010
646 SKIN LESION 27 0.0010
647 PANCYTOPENIA 55 0.0010
648 DEVICE DIFFICULT TO USE 65 0.0010
649 MATERNAL EXPOSURE DURING PREGNANCY 87 0.0010
650 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
651 DRY MOUTH 79 0.0010
652 NEUROPATHY PERIPHERAL 92 0.0010
653 DISCOMFORT 59 0.0010
654 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
655 EJECTION FRACTION DECREASED 15 0.0010
656 ARTHRALGIA 401 0.0010
657 CLOSTRIDIUM DIFFICILE INFECTION 21 0.0010
658 PLATELET COUNT DECREASED 102 0.0010
659 CARDIAC ARREST 79 0.0010
660 BONE PAIN 56 0.0010
661 PERICARDITIS 16 0.0010
662 CEREBRAL HAEMORRHAGE 34 0.0009
663 BLOOD URINE PRESENT 18 0.0009
664 CHRONIC KIDNEY DISEASE 72 0.0009
665 INCONTINENCE 10 0.0009
666 ANGINA PECTORIS 27 0.0009
667 GASTROENTERITIS VIRAL 17 0.0009
668 LOWER LIMB FRACTURE 18 0.0009
669 ROTATOR CUFF SYNDROME 12 0.0009
670 NIGHT SWEATS 30 0.0009
671 HYPOGLYCAEMIA 45 0.0009
672 APHASIA 28 0.0009
673 DEPRESSED MOOD 49 0.0009
674 BLOOD TEST ABNORMAL 13 0.0009
675 HAEMOGLOBIN DECREASED 95 0.0009
676 DYSPEPSIA 91 0.0009
677 PRURITUS GENERALISED 20 0.0009
678 HAEMATOCHEZIA 51 0.0009
679 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
680 PRODUCTIVE COUGH 44 0.0009
681 OFF LABEL USE 805 0.0009
682 OROPHARYNGEAL PAIN 85 0.0009
683 CONJUNCTIVITIS 17 0.0009
684 PALPITATIONS 107 0.0009
685 ANHEDONIA 24 0.0009
686 AMENORRHOEA 16 0.0009
687 MUSCLE TWITCHING 21 0.0009
688 METASTASES TO LIVER 16 0.0009
689 HYPOPHAGIA 23 0.0009
690 JOINT RANGE OF MOTION DECREASED 12 0.0009
691 CARDIOMEGALY 11 0.0009
692 BRAIN FOG 14 0.0009
693 BRONCHITIS 66 0.0009
694 HYPERCALCAEMIA 11 0.0009
695 BLOOD CALCIUM DECREASED 10 0.0009
696 FEEDING DISORDER 18 0.0009
697 DRUG TOXICITY 12 0.0009
698 PNEUMONIA 285 0.0009
699 MUCOSAL INFLAMMATION 23 0.0009
700 BONE DISORDER 16 0.0009
701 RIB FRACTURE 18 0.0009
702 BRAIN OEDEMA 11 0.0009
703 MUSCLE ATROPHY 11 0.0009
704 MUSCLE TIGHTNESS 14 0.0009
705 FEBRILE NEUTROPENIA 57 0.0009
706 ACTIVITIES OF DAILY LIVING IMPAIRED 17 0.0009
707 PARAESTHESIA 135 0.0009
708 NASOPHARYNGITIS 158 0.0009
709 GASTROOESOPHAGEAL REFLUX DISEASE 69 0.0009
710 CARPAL TUNNEL SYNDROME 12 0.0009
711 NEUTROPENIA 116 0.0009
712 SYNCOPE 85 0.0008
713 BLOOD SODIUM DECREASED 16 0.0008
714 COVID-19 PNEUMONIA 10 0.0008
715 EATING DISORDER 18 0.0008
716 NODULE 11 0.0008
717 JOINT INJURY 18 0.0008
718 ANKLE FRACTURE 13 0.0008
719 LUNG INFECTION 13 0.0008
720 IMMUNE SYSTEM DISORDER 11 0.0008
721 PULMONARY FIBROSIS 16 0.0008
722 TINNITUS 38 0.0008
723 WHEEZING 49 0.0008
724 MALIGNANT MELANOMA 11 0.0008
725 DIZZINESS 409 0.0008
726 ACUTE MYOCARDIAL INFARCTION 24 0.0008
727 COGNITIVE DISORDER 38 0.0008
728 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 39 0.0008
729 DEHYDRATION 108 0.0008
730 COUGH 227 0.0008
731 NIGHTMARE 28 0.0008
732 LIMB DISCOMFORT 25 0.0008
733 STOMATITIS 49 0.0008
734 CATARACT 48 0.0008
735 CYST 10 0.0008
736 ILLNESS 83 0.0008
737 MENTAL DISORDER 35 0.0008
738 ABDOMINAL DISCOMFORT 134 0.0008
739 RENAL IMPAIRMENT 67 0.0008
740 ABDOMINAL DISTENSION 83 0.0008
741 BLOOD CHOLESTEROL INCREASED 37 0.0008
742 LYMPHADENOPATHY 28 0.0008
743 ILL-DEFINED DISORDER 48 0.0008
744 ROAD TRAFFIC ACCIDENT 33 0.0008
745 DYSURIA 29 0.0008
746 OSTEOPOROSIS 32 0.0008
747 MALAISE 341 0.0008
748 AGITATION 57 0.0008
749 FALL 258 0.0008
750 RHINORRHOEA 50 0.0008
751 INJECTION SITE INDURATION 10 0.0008
752 BURNING SENSATION 54 0.0008
753 PANIC ATTACK 28 0.0008
754 MOBILITY DECREASED 55 0.0008
755 ACCIDENTAL OVERDOSE 28 0.0008
756 DEPRESSION 174 0.0008
757 IMPAIRED HEALING 25 0.0008
758 NEUTROPHIL COUNT DECREASED 31 0.0008
759 FOETAL EXPOSURE DURING PREGNANCY 61 0.0007
760 FUNGAL INFECTION 25 0.0007
761 TREATMENT NONCOMPLIANCE 41 0.0007
762 FLUSHING 76 0.0007
763 MOVEMENT DISORDER 24 0.0007
764 HEPATIC CIRRHOSIS 14 0.0007
765 EYE PAIN 42 0.0007
766 LOCALISED INFECTION 18 0.0007
767 CRYING 27 0.0007
768 URINARY TRACT INFECTION 126 0.0007
769 COLON CANCER 11 0.0007
770 RESTLESSNESS 27 0.0007
771 SLEEP DISORDER 52 0.0007
772 PNEUMONITIS 20 0.0007
773 HEAD DISCOMFORT 13 0.0007
774 GINGIVAL BLEEDING 10 0.0007
775 DIPLOPIA 19 0.0007
776 GAIT DISTURBANCE 140 0.0007
777 MUSCULAR WEAKNESS 83 0.0007
778 LUNG NEOPLASM MALIGNANT 30 0.0007
779 ATRIAL FIBRILLATION 71 0.0007
780 CORONARY ARTERY DISEASE 22 0.0007
781 ECONOMIC PROBLEM 11 0.0007
782 DYSPHONIA 42 0.0007
783 DERMATITIS 15 0.0007
784 PRURITUS 275 0.0007
785 NASAL CONGESTION 42 0.0007
786 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
787 HYPERGLYCAEMIA 26 0.0007
788 BLOOD PRESSURE INCREASED 109 0.0007
789 CHEST DISCOMFORT 73 0.0007
790 MOUTH ULCERATION 15 0.0007
791 CANDIDA INFECTION 12 0.0007
792 INSOMNIA 189 0.0007
793 ACUTE MYELOID LEUKAEMIA 11 0.0007
794 PRESCRIBED UNDERDOSE 14 0.0007
795 IRRITABLE BOWEL SYNDROME 15 0.0007
796 PRODUCT ADMINISTRATION ERROR 14 0.0007
797 HOT FLUSH 52 0.0007
798 SKIN DISORDER 23 0.0007
799 BONE MARROW FAILURE 14 0.0007
800 DEVICE USE ISSUE 12 0.0007
801 CONTUSION 66 0.0007
802 SENSORY DISTURBANCE 11 0.0007
803 MENTAL STATUS CHANGES 19 0.0007
804 WEIGHT INCREASED 153 0.0007
805 PRODUCT USE IN UNAPPROVED INDICATION 169 0.0007
806 HERPES ZOSTER 39 0.0007
807 DEEP VEIN THROMBOSIS 44 0.0007
808 GALLBLADDER DISORDER 12 0.0007
809 GASTROINTESTINAL DISORDER 60 0.0007
810 RASH PRURITIC 36 0.0007
811 INTESTINAL OBSTRUCTION 25 0.0007
812 BLISTER 37 0.0007
813 HYPOAESTHESIA 98 0.0007
814 NEEDLE ISSUE 19 0.0007
815 POOR QUALITY SLEEP 14 0.0006
816 AMNESIA 42 0.0006
817 TREMOR 107 0.0006
818 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
819 BODY TEMPERATURE INCREASED 13 0.0006
820 VISION BLURRED 87 0.0006
821 RED BLOOD CELL COUNT DECREASED 18 0.0006
822 HYPOACUSIS 27 0.0006
823 ABSCESS 10 0.0006
824 HEART RATE DECREASED 22 0.0006
825 HYPOTHYROIDISM 20 0.0006
826 THROAT IRRITATION 28 0.0006
827 TYPE 2 DIABETES MELLITUS 21 0.0006
828 FEELING ABNORMAL 149 0.0006
829 RASH GENERALISED 16 0.0006
830 THIRST 11 0.0006
831 GOUT 11 0.0006
832 DISTURBANCE IN ATTENTION 33 0.0006
833 ABASIA 15 0.0006
834 LIVER FUNCTION TEST INCREASED 13 0.0006
835 MALIGNANT NEOPLASM PROGRESSION 62 0.0006
836 CYTOMEGALOVIRUS INFECTION 10 0.0006
837 EAR INFECTION 16 0.0006
838 RASH MACULAR 21 0.0006
839 HEAD INJURY 19 0.0006
840 COAGULOPATHY 10 0.0006
841 SWELLING FACE 39 0.0006
842 DRUG INEFFECTIVE 786 0.0006
843 TASTE DISORDER 12 0.0006
844 FEELING HOT 36 0.0006
845 UNRESPONSIVE TO STIMULI 15 0.0006
846 RESPIRATORY ARREST 16 0.0006
847 BALANCE DISORDER 50 0.0006
848 CONVULSION 33 0.0006
849 POLLAKIURIA 24 0.0006
850 ECZEMA 30 0.0006
851 ANXIETY 163 0.0006
852 WHITE BLOOD CELL COUNT DECREASED 62 0.0006
853 CHILLS 67 0.0006
854 INTENTIONAL PRODUCT USE ISSUE 50 0.0006
855 ISCHAEMIC STROKE 10 0.0006
856 HYPERSOMNIA 16 0.0006
857 RENAL DISORDER 26 0.0006
858 DYSARTHRIA 21 0.0006
859 HALLUCINATION 42 0.0006
860 VISUAL IMPAIRMENT 69 0.0006
861 SINUS DISORDER 11 0.0006
862 BLOOD PRESSURE ABNORMAL 11 0.0006
863 GASTRIC CANCER 14 0.0006
864 PRODUCT PRESCRIBING ISSUE 12 0.0006
865 SKIN DISCOLOURATION 25 0.0005
866 DYSKINESIA 22 0.0005
867 DIVERTICULITIS 15 0.0005
868 INJURY 38 0.0005
869 EYE PRURITUS 18 0.0005
870 HAEMORRHAGE 56 0.0005
871 SNEEZING 12 0.0005
872 HEART RATE IRREGULAR 12 0.0005
873 LACRIMATION INCREASED 16 0.0005
874 FOOT FRACTURE 10 0.0005
875 COVID-19 92 0.0005
876 AGEUSIA 13 0.0005
877 ERUCTATION 10 0.0005
878 DRUG DEPENDENCE 83 0.0005
879 DYSSTASIA 15 0.0005
880 SUICIDAL IDEATION 47 0.0005
881 LABORATORY TEST ABNORMAL 15 0.0005
882 HAEMATOCRIT DECREASED 10 0.0005
883 CYTOKINE RELEASE SYNDROME 10 0.0005
884 NERVOUSNESS 26 0.0005
885 SEDATION 13 0.0005
886 FULL BLOOD COUNT DECREASED 10 0.0005
887 ORAL PAIN 11 0.0005
888 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
889 GAIT INABILITY 16 0.0005
890 CARDIOVASCULAR DISORDER 12 0.0005
891 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
892 THROMBOSIS 38 0.0005
893 SINUSITIS 48 0.0005
894 PSORIATIC ARTHROPATHY 19 0.0005
895 FEELING COLD 13 0.0005
896 BLINDNESS 19 0.0005
897 ALOPECIA 91 0.0005
898 INFLUENZA LIKE ILLNESS 38 0.0005
899 CARDIAC FAILURE CONGESTIVE 37 0.0005
900 DEAFNESS 12 0.0005
901 MUSCLE SPASMS 84 0.0005
902 OSTEONECROSIS 15 0.0005
903 APPLICATION SITE PAIN 10 0.0005
904 HEPATOTOXICITY 10 0.0004
905 CARDIAC DISORDER 42 0.0004
906 SWOLLEN TONGUE 14 0.0004
907 ENCEPHALOPATHY 11 0.0004
908 PRODUCT ADHESION ISSUE 16 0.0004
909 LIVER FUNCTION TEST ABNORMAL 13 0.0004
910 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
911 MYOCARDIAL INFARCTION 77 0.0004
912 SPEECH DISORDER 23 0.0004
913 GASTRIC DISORDER 15 0.0004
914 PLASMA CELL MYELOMA 17 0.0004
915 HIP FRACTURE 14 0.0004
916 ABDOMINAL PAIN LOWER 11 0.0004
917 PREMATURE BABY 13 0.0004
918 NEOPLASM PROGRESSION 15 0.0004
919 THERAPEUTIC RESPONSE DECREASED 26 0.0004
920 WITHDRAWAL SYNDROME 18 0.0004
921 INCORRECT DRUG ADMINISTRATION DURATION 12 0.0004
922 EXPOSURE VIA SKIN CONTACT 11 0.0004
923 RESPIRATORY TRACT INFECTION 11 0.0004
924 AGGRESSION 21 0.0004
925 LETHARGY 24 0.0004
926 IRRITABILITY 25 0.0004
927 MEMORY IMPAIRMENT 57 0.0004
928 WRONG TECHNIQUE IN DRUG USAGE PROCESS 15 0.0004
929 FEAR 11 0.0004
930 FREQUENT BOWEL MOVEMENTS 11 0.0004
931 SEIZURE 47 0.0004
932 RENAL INJURY 12 0.0004
933 ABNORMAL BEHAVIOUR 16 0.0004
934 PROSTATE CANCER 32 0.0004
935 FLATULENCE 22 0.0004
936 BREAST CANCER 36 0.0004
937 JOINT STIFFNESS 10 0.0004
938 SKIN EXFOLIATION 32 0.0004
939 BLOOD GLUCOSE DECREASED 18 0.0004
940 BREAST CANCER FEMALE 10 0.0004
941 DRUG EFFECT DECREASED 20 0.0004
942 VISUAL ACUITY REDUCED 12 0.0004
943 COLITIS ULCERATIVE 16 0.0004
944 DEMENTIA 10 0.0004
945 PRODUCT DOSE OMISSION ISSUE 105 0.0004
946 ADVERSE DRUG REACTION 32 0.0004
947 EMOTIONAL DISTRESS 43 0.0004
948 DRUG EXPOSURE DURING PREGNANCY 12 0.0004
949 DISEASE PROGRESSION 41 0.0003
950 INJECTION SITE SWELLING 26 0.0003
951 EXPIRED PRODUCT ADMINISTERED 11 0.0003
952 UNEVALUABLE EVENT 25 0.0003
953 LIP SWELLING 11 0.0003
954 ANGER 11 0.0003
955 INJECTION SITE ERYTHEMA 39 0.0003
956 INJECTION SITE PRURITUS 21 0.0003
957 CEREBROVASCULAR ACCIDENT 53 0.0003
958 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
959 INJECTION SITE REACTION 21 0.0003
960 UNDERDOSE 22 0.0003
961 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 14 0.0003
962 DYSGEUSIA 22 0.0003
963 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
964 EYE SWELLING 11 0.0003
965 INCORRECT DOSE ADMINISTERED 66 0.0003
966 NEOPLASM MALIGNANT 19 0.0003
967 INJECTION SITE PAIN 87 0.0003
968 OCULAR HYPERAEMIA 13 0.0003
969 MULTIPLE SCLEROSIS 13 0.0003
970 ADVERSE EVENT 25 0.0003
971 DEVICE BREAKAGE 11 0.0003
972 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 48 0.0003
973 COMPLETED SUICIDE 22 0.0003
974 DRUG WITHDRAWAL SYNDROME 23 0.0003
975 SKIN IRRITATION 12 0.0003
976 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
977 MULTIPLE SCLEROSIS RELAPSE 17 0.0002
978 EXTRA DOSE ADMINISTERED 10 0.0002
979 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
980 DRY EYE 12 0.0002
981 SURGERY 14 0.0002
982 INJECTION SITE BRUISING 19 0.0002
983 DISEASE RECURRENCE 11 0.0002
984 BLOOD GLUCOSE INCREASED 42 0.0002
985 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
986 ACNE 16 0.0002
987 DRY SKIN 28 0.0002
988 INJECTION SITE HAEMORRHAGE 16 0.0002
989 EYE IRRITATION 11 0.0002
990 HOSPITALISATION 26 0.0002
991 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
992 DEATH 139 0.0002
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 32 0.0002
994 NO ADVERSE EVENT 18 0.0001
995 PRODUCT QUALITY ISSUE 13 0.0001